Utah Medical Products, Inc. (NASDAQ:UTMD) Shares Purchased by JPMorgan Chase & Co.

JPMorgan Chase & Co. boosted its holdings in Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 14.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 79,703 shares of the medical instruments supplier's stock after purchasing an additional 10,292 shares during the quarter. JPMorgan Chase & Co. owned about 2.35% of Utah Medical Products worth $4,899,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in UTMD. LPL Financial LLC acquired a new stake in shares of Utah Medical Products in the fourth quarter valued at about $208,000. American Century Companies Inc. grew its position in shares of Utah Medical Products by 8.6% in the fourth quarter. American Century Companies Inc. now owns 8,135 shares of the medical instruments supplier's stock valued at $500,000 after purchasing an additional 643 shares during the period. Royce & Associates LP increased its stake in shares of Utah Medical Products by 159.0% during the 4th quarter. Royce & Associates LP now owns 41,958 shares of the medical instruments supplier's stock valued at $2,579,000 after acquiring an additional 25,755 shares during the last quarter. Brandes Investment Partners LP boosted its holdings in shares of Utah Medical Products by 17.8% in the 4th quarter. Brandes Investment Partners LP now owns 162,969 shares of the medical instruments supplier's stock valued at $10,018,000 after purchasing an additional 24,604 shares during the last quarter. Finally, Atria Investments Inc grew its position in Utah Medical Products by 23.8% during the fourth quarter. Atria Investments Inc now owns 8,899 shares of the medical instruments supplier's stock valued at $547,000 after acquiring an additional 1,712 shares during the period. 69.60% of the stock is owned by hedge funds and other institutional investors.

Utah Medical Products Stock Down 0.2 %

Utah Medical Products stock opened at $52.30 on Friday. Utah Medical Products, Inc. has a 52-week low of $52.27 and a 52-week high of $77.33. The firm has a fifty day moving average of $57.18 and a 200-day moving average of $61.38. The firm has a market capitalization of $171.65 million, a P/E ratio of 13.24 and a beta of 0.17.

Utah Medical Products (NASDAQ:UTMD - Get Free Report) last announced its earnings results on Tuesday, January 28th. The medical instruments supplier reported $0.86 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%.

Utah Medical Products Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, April 3rd. Shareholders of record on Friday, March 14th were given a $0.305 dividend. This represents a $1.22 annualized dividend and a yield of 2.33%. The ex-dividend date of this dividend was Friday, March 14th. Utah Medical Products's dividend payout ratio is presently 30.89%.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.

Want to see what other hedge funds are holding UTMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.